nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF4—appendage—skin cancer	0.0862	0.264	CbGeAlD
Pentosan Polysulfate—FGF1—dermis—skin cancer	0.0451	0.138	CbGeAlD
Pentosan Polysulfate—FGF4—connective tissue—skin cancer	0.0246	0.0754	CbGeAlD
Pentosan Polysulfate—FGF1—appendage—skin cancer	0.0228	0.0698	CbGeAlD
Pentosan Polysulfate—FGF1—skin epidermis—skin cancer	0.019	0.0581	CbGeAlD
Pentosan Polysulfate—FGF4—female reproductive system—skin cancer	0.0174	0.0532	CbGeAlD
Pentosan Polysulfate—FGF1—nerve—skin cancer	0.0162	0.0495	CbGeAlD
Pentosan Polysulfate—FGF4—head—skin cancer	0.0145	0.0444	CbGeAlD
Pentosan Polysulfate—FGF1—endothelium—skin cancer	0.0138	0.0421	CbGeAlD
Pentosan Polysulfate—FGF1—blood vessel—skin cancer	0.0127	0.0388	CbGeAlD
Pentosan Polysulfate—FGF1—neck—skin cancer	0.00908	0.0278	CbGeAlD
Pentosan Polysulfate—FGF2—mammalian vulva—skin cancer	0.0072	0.0221	CbGeAlD
Pentosan Polysulfate—FGF1—connective tissue—skin cancer	0.0065	0.0199	CbGeAlD
Pentosan Polysulfate—FGF1—epithelium—skin cancer	0.00618	0.0189	CbGeAlD
Pentosan Polysulfate—FGF1—skin of body—skin cancer	0.00587	0.018	CbGeAlD
Pentosan Polysulfate—FGF1—lymphoid tissue—skin cancer	0.00476	0.0146	CbGeAlD
Pentosan Polysulfate—FGF1—female reproductive system—skin cancer	0.00459	0.014	CbGeAlD
Pentosan Polysulfate—FGF1—head—skin cancer	0.00383	0.0117	CbGeAlD
Pentosan Polysulfate—FGF2—lymph node—skin cancer	0.00361	0.011	CbGeAlD
Pentosan Polysulfate—FGF1—lymph node—skin cancer	0.00268	0.00822	CbGeAlD
Pentosan Polysulfate—Lacrimation—Docetaxel—skin cancer	0.00251	0.0081	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Vemurafenib—skin cancer	0.00249	0.00803	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Vemurafenib—skin cancer	0.00247	0.00796	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00229	0.00737	CcSEcCtD
Pentosan Polysulfate—Sweating increased—Imiquimod—skin cancer	0.00227	0.0073	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Dactinomycin—skin cancer	0.00225	0.00724	CcSEcCtD
Pentosan Polysulfate—Vaginal inflammation—Temozolomide—skin cancer	0.00222	0.00716	CcSEcCtD
Pentosan Polysulfate—Lacrimation increased—Fluorouracil—skin cancer	0.00222	0.00716	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Dactinomycin—skin cancer	0.00222	0.00716	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Vismodegib—skin cancer	0.00221	0.00712	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Vismodegib—skin cancer	0.00218	0.00704	CcSEcCtD
Pentosan Polysulfate—Constipation—Vismodegib—skin cancer	0.00215	0.00692	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Imiquimod—skin cancer	0.00212	0.00684	CcSEcCtD
Pentosan Polysulfate—Vaginal infection—Temozolomide—skin cancer	0.0021	0.00676	CcSEcCtD
Pentosan Polysulfate—Depression—Imiquimod—skin cancer	0.00207	0.00667	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Vismodegib—skin cancer	0.00205	0.00662	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Imiquimod—skin cancer	0.00202	0.0065	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Vismodegib—skin cancer	0.00199	0.0064	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Imiquimod—skin cancer	0.00195	0.00627	CcSEcCtD
Pentosan Polysulfate—Alopecia—Vemurafenib—skin cancer	0.00193	0.00622	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Fluorouracil—skin cancer	0.00187	0.00603	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Imiquimod—skin cancer	0.00187	0.00602	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Imiquimod—skin cancer	0.00185	0.00596	CcSEcCtD
Pentosan Polysulfate—Pruritus—Vismodegib—skin cancer	0.00178	0.00573	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Imiquimod—skin cancer	0.00174	0.0056	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Vismodegib—skin cancer	0.00172	0.00554	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Fluorouracil—skin cancer	0.00169	0.00546	CcSEcCtD
Pentosan Polysulfate—Amenorrhoea—Docetaxel—skin cancer	0.00168	0.00542	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Dactinomycin—skin cancer	0.00165	0.00531	CcSEcCtD
Pentosan Polysulfate—Alopecia—Imiquimod—skin cancer	0.00165	0.0053	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Vemurafenib—skin cancer	0.00162	0.00522	CcSEcCtD
Pentosan Polysulfate—Myalgia—Vemurafenib—skin cancer	0.00162	0.00522	CcSEcCtD
Pentosan Polysulfate—Lacrimation increased—Docetaxel—skin cancer	0.0016	0.00517	CcSEcCtD
Pentosan Polysulfate—Vomiting—Vismodegib—skin cancer	0.0016	0.00515	CcSEcCtD
Pentosan Polysulfate—Affect lability—Temozolomide—skin cancer	0.00159	0.00512	CcSEcCtD
Pentosan Polysulfate—Rash—Vismodegib—skin cancer	0.00158	0.0051	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Vismodegib—skin cancer	0.00158	0.0051	CcSEcCtD
Pentosan Polysulfate—Infection—Vemurafenib—skin cancer	0.00154	0.00497	CcSEcCtD
Pentosan Polysulfate—Mood swings—Temozolomide—skin cancer	0.00153	0.00493	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Imiquimod—skin cancer	0.0015	0.00485	CcSEcCtD
Pentosan Polysulfate—Dehydration—Temozolomide—skin cancer	0.0015	0.00484	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Bleomycin—skin cancer	0.0015	0.00482	CcSEcCtD
Pentosan Polysulfate—Nausea—Vismodegib—skin cancer	0.00149	0.00481	CcSEcCtD
Pentosan Polysulfate—Agitation—Imiquimod—skin cancer	0.00149	0.0048	CcSEcCtD
Pentosan Polysulfate—Malaise—Imiquimod—skin cancer	0.00146	0.00471	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Bleomycin—skin cancer	0.00144	0.00463	CcSEcCtD
Pentosan Polysulfate—Colitis—Docetaxel—skin cancer	0.00142	0.00457	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00141	0.00456	CcSEcCtD
Pentosan Polysulfate—Haematuria—Bleomycin—skin cancer	0.00141	0.00453	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Imiquimod—skin cancer	0.00138	0.00445	CcSEcCtD
Pentosan Polysulfate—Myalgia—Imiquimod—skin cancer	0.00138	0.00445	CcSEcCtD
Pentosan Polysulfate—Discomfort—Imiquimod—skin cancer	0.00136	0.0044	CcSEcCtD
Pentosan Polysulfate—Sweating increased—Temozolomide—skin cancer	0.00136	0.00438	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Docetaxel—skin cancer	0.00135	0.00435	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Vemurafenib—skin cancer	0.00135	0.00435	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Dactinomycin—skin cancer	0.00134	0.00432	CcSEcCtD
Pentosan Polysulfate—Constipation—Vemurafenib—skin cancer	0.00133	0.00428	CcSEcCtD
Pentosan Polysulfate—Oedema—Imiquimod—skin cancer	0.00132	0.00426	CcSEcCtD
Pentosan Polysulfate—Infection—Imiquimod—skin cancer	0.00132	0.00424	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Temozolomide—skin cancer	0.00129	0.00415	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Imiquimod—skin cancer	0.00128	0.00412	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Temozolomide—skin cancer	0.00127	0.0041	CcSEcCtD
Pentosan Polysulfate—Weight increased—Temozolomide—skin cancer	0.00127	0.00409	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Temozolomide—skin cancer	0.00126	0.00407	CcSEcCtD
Pentosan Polysulfate—Anorexia—Imiquimod—skin cancer	0.00126	0.00406	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Fluorouracil—skin cancer	0.00125	0.00403	CcSEcCtD
Pentosan Polysulfate—Depression—Temozolomide—skin cancer	0.00124	0.004	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Dactinomycin—skin cancer	0.00123	0.00395	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Temozolomide—skin cancer	0.00121	0.00391	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00121	0.00389	CcSEcCtD
Pentosan Polysulfate—Insomnia—Imiquimod—skin cancer	0.0012	0.00386	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Imiquimod—skin cancer	0.00119	0.00383	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Imiquimod—skin cancer	0.00118	0.0038	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Fluorouracil—skin cancer	0.00117	0.00378	CcSEcCtD
Pentosan Polysulfate—Alopecia—Bleomycin—skin cancer	0.00117	0.00377	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Temozolomide—skin cancer	0.00117	0.00376	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Imiquimod—skin cancer	0.00117	0.00375	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Imiquimod—skin cancer	0.00115	0.00371	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Vemurafenib—skin cancer	0.00114	0.00368	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Fluorouracil—skin cancer	0.00112	0.0036	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Fluorouracil—skin cancer	0.00111	0.00359	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Temozolomide—skin cancer	0.00111	0.00357	CcSEcCtD
Pentosan Polysulfate—Pruritus—Vemurafenib—skin cancer	0.0011	0.00354	CcSEcCtD
Pentosan Polysulfate—Alopecia—Dactinomycin—skin cancer	0.00109	0.00351	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Imiquimod—skin cancer	0.00109	0.00351	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Imiquimod—skin cancer	0.00108	0.00349	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Fluorouracil—skin cancer	0.00108	0.00348	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Fluorouracil—skin cancer	0.00108	0.00346	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Bleomycin—skin cancer	0.00107	0.00344	CcSEcCtD
Pentosan Polysulfate—Anaemia—Bleomycin—skin cancer	0.00106	0.00343	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Vemurafenib—skin cancer	0.00106	0.00342	CcSEcCtD
Pentosan Polysulfate—Urticaria—Imiquimod—skin cancer	0.00105	0.00339	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Imiquimod—skin cancer	0.00105	0.00337	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Temozolomide—skin cancer	0.00104	0.00335	CcSEcCtD
Pentosan Polysulfate—Malaise—Bleomycin—skin cancer	0.00104	0.00335	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Bleomycin—skin cancer	0.00103	0.00332	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Fluorouracil—skin cancer	0.00103	0.00332	CcSEcCtD
Pentosan Polysulfate—Dizziness—Vemurafenib—skin cancer	0.00103	0.00331	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Fluorouracil—skin cancer	0.00102	0.00329	CcSEcCtD
Pentosan Polysulfate—Dehydration—Docetaxel—skin cancer	0.000998	0.00322	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Dactinomycin—skin cancer	0.000997	0.00321	CcSEcCtD
Pentosan Polysulfate—Anaemia—Dactinomycin—skin cancer	0.000993	0.0032	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Docetaxel—skin cancer	0.000991	0.00319	CcSEcCtD
Pentosan Polysulfate—Vomiting—Vemurafenib—skin cancer	0.000987	0.00318	CcSEcCtD
Pentosan Polysulfate—Alopecia—Temozolomide—skin cancer	0.000987	0.00318	CcSEcCtD
Pentosan Polysulfate—Myalgia—Bleomycin—skin cancer	0.000981	0.00316	CcSEcCtD
Pentosan Polysulfate—Rash—Vemurafenib—skin cancer	0.000979	0.00315	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Vemurafenib—skin cancer	0.000978	0.00315	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Imiquimod—skin cancer	0.000975	0.00314	CcSEcCtD
Pentosan Polysulfate—Headache—Vemurafenib—skin cancer	0.000972	0.00313	CcSEcCtD
Pentosan Polysulfate—Discomfort—Bleomycin—skin cancer	0.000969	0.00312	CcSEcCtD
Pentosan Polysulfate—Malaise—Dactinomycin—skin cancer	0.000969	0.00312	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Dactinomycin—skin cancer	0.000962	0.0031	CcSEcCtD
Pentosan Polysulfate—Oedema—Bleomycin—skin cancer	0.00094	0.00303	CcSEcCtD
Pentosan Polysulfate—Pruritus—Imiquimod—skin cancer	0.000937	0.00302	CcSEcCtD
Pentosan Polysulfate—Infection—Bleomycin—skin cancer	0.000934	0.00301	CcSEcCtD
Pentosan Polysulfate—Nausea—Vemurafenib—skin cancer	0.000922	0.00297	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Bleomycin—skin cancer	0.000921	0.00297	CcSEcCtD
Pentosan Polysulfate—Myalgia—Dactinomycin—skin cancer	0.000915	0.00295	CcSEcCtD
Pentosan Polysulfate—Alopecia—Fluorouracil—skin cancer	0.000909	0.00293	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Imiquimod—skin cancer	0.000906	0.00292	CcSEcCtD
Pentosan Polysulfate—Discomfort—Dactinomycin—skin cancer	0.000904	0.00291	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Docetaxel—skin cancer	0.000904	0.00291	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Temozolomide—skin cancer	0.000902	0.00291	CcSEcCtD
Pentosan Polysulfate—Anaemia—Temozolomide—skin cancer	0.000898	0.00289	CcSEcCtD
Pentosan Polysulfate—Anorexia—Bleomycin—skin cancer	0.000896	0.00289	CcSEcCtD
Pentosan Polysulfate—Agitation—Temozolomide—skin cancer	0.000893	0.00288	CcSEcCtD
Pentosan Polysulfate—Oedema—Dactinomycin—skin cancer	0.000877	0.00283	CcSEcCtD
Pentosan Polysulfate—Malaise—Temozolomide—skin cancer	0.000877	0.00282	CcSEcCtD
Pentosan Polysulfate—Dizziness—Imiquimod—skin cancer	0.000875	0.00282	CcSEcCtD
Pentosan Polysulfate—Infection—Dactinomycin—skin cancer	0.000871	0.00281	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Temozolomide—skin cancer	0.00087	0.0028	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Dactinomycin—skin cancer	0.000859	0.00277	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000857	0.00276	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Bleomycin—skin cancer	0.000844	0.00272	CcSEcCtD
Pentosan Polysulfate—Weight increased—Docetaxel—skin cancer	0.000844	0.00272	CcSEcCtD
Pentosan Polysulfate—Vomiting—Imiquimod—skin cancer	0.000842	0.00271	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Docetaxel—skin cancer	0.000839	0.0027	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Bleomycin—skin cancer	0.000838	0.0027	CcSEcCtD
Pentosan Polysulfate—Anorexia—Dactinomycin—skin cancer	0.000836	0.00269	CcSEcCtD
Pentosan Polysulfate—Rash—Imiquimod—skin cancer	0.000835	0.00269	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Imiquimod—skin cancer	0.000834	0.00269	CcSEcCtD
Pentosan Polysulfate—Headache—Imiquimod—skin cancer	0.000829	0.00267	CcSEcCtD
Pentosan Polysulfate—Anaemia—Fluorouracil—skin cancer	0.000828	0.00267	CcSEcCtD
Pentosan Polysulfate—Myalgia—Temozolomide—skin cancer	0.000827	0.00267	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Temozolomide—skin cancer	0.000827	0.00267	CcSEcCtD
Pentosan Polysulfate—Discomfort—Temozolomide—skin cancer	0.000818	0.00263	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Bleomycin—skin cancer	0.000817	0.00263	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Docetaxel—skin cancer	0.000806	0.0026	CcSEcCtD
Pentosan Polysulfate—Jaundice—Docetaxel—skin cancer	0.000806	0.0026	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Docetaxel—skin cancer	0.000804	0.00259	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Fluorouracil—skin cancer	0.000802	0.00258	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000799	0.00257	CcSEcCtD
Pentosan Polysulfate—Oedema—Temozolomide—skin cancer	0.000793	0.00256	CcSEcCtD
Pentosan Polysulfate—Infection—Temozolomide—skin cancer	0.000788	0.00254	CcSEcCtD
Pentosan Polysulfate—Nausea—Imiquimod—skin cancer	0.000786	0.00253	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Docetaxel—skin cancer	0.00078	0.00251	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Temozolomide—skin cancer	0.000777	0.0025	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Bleomycin—skin cancer	0.000775	0.0025	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Temozolomide—skin cancer	0.000767	0.00247	CcSEcCtD
Pentosan Polysulfate—Myalgia—Fluorouracil—skin cancer	0.000762	0.00246	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Dactinomycin—skin cancer	0.000762	0.00246	CcSEcCtD
Pentosan Polysulfate—Anorexia—Temozolomide—skin cancer	0.000756	0.00244	CcSEcCtD
Pentosan Polysulfate—Discomfort—Fluorouracil—skin cancer	0.000753	0.00243	CcSEcCtD
Pentosan Polysulfate—Urticaria—Bleomycin—skin cancer	0.000747	0.00241	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Docetaxel—skin cancer	0.000744	0.0024	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Docetaxel—skin cancer	0.000737	0.00237	CcSEcCtD
Pentosan Polysulfate—Oedema—Fluorouracil—skin cancer	0.000731	0.00235	CcSEcCtD
Pentosan Polysulfate—Infection—Fluorouracil—skin cancer	0.000726	0.00234	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Dactinomycin—skin cancer	0.000723	0.00233	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000723	0.00233	CcSEcCtD
Pentosan Polysulfate—Insomnia—Temozolomide—skin cancer	0.000717	0.00231	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Dactinomycin—skin cancer	0.000717	0.00231	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Fluorouracil—skin cancer	0.000716	0.00231	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Temozolomide—skin cancer	0.000712	0.00229	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Temozolomide—skin cancer	0.000707	0.00228	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Temozolomide—skin cancer	0.000698	0.00225	CcSEcCtD
Pentosan Polysulfate—Anorexia—Fluorouracil—skin cancer	0.000697	0.00224	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Dactinomycin—skin cancer	0.000693	0.00223	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Bleomycin—skin cancer	0.000693	0.00223	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Temozolomide—skin cancer	0.00069	0.00222	CcSEcCtD
Pentosan Polysulfate—Constipation—Temozolomide—skin cancer	0.000678	0.00219	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000666	0.00215	CcSEcCtD
Pentosan Polysulfate—Pruritus—Bleomycin—skin cancer	0.000665	0.00214	CcSEcCtD
Pentosan Polysulfate—Insomnia—Fluorouracil—skin cancer	0.000661	0.00213	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Fluorouracil—skin cancer	0.000656	0.00211	CcSEcCtD
Pentosan Polysulfate—Alopecia—Docetaxel—skin cancer	0.000656	0.00211	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Temozolomide—skin cancer	0.000654	0.00211	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Fluorouracil—skin cancer	0.000652	0.0021	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Temozolomide—skin cancer	0.000649	0.00209	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Dactinomycin—skin cancer	0.000646	0.00208	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Fluorouracil—skin cancer	0.000643	0.00207	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Fluorouracil—skin cancer	0.000635	0.00205	CcSEcCtD
Pentosan Polysulfate—Urticaria—Temozolomide—skin cancer	0.00063	0.00203	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Temozolomide—skin cancer	0.000627	0.00202	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Fluorouracil—skin cancer	0.000602	0.00194	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Dactinomycin—skin cancer	0.0006	0.00193	CcSEcCtD
Pentosan Polysulfate—Vomiting—Bleomycin—skin cancer	0.000598	0.00193	CcSEcCtD
Pentosan Polysulfate—Anaemia—Docetaxel—skin cancer	0.000597	0.00192	CcSEcCtD
Pentosan Polysulfate—Rash—Bleomycin—skin cancer	0.000593	0.00191	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Bleomycin—skin cancer	0.000592	0.00191	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Temozolomide—skin cancer	0.000584	0.00188	CcSEcCtD
Pentosan Polysulfate—Urticaria—Fluorouracil—skin cancer	0.000581	0.00187	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Docetaxel—skin cancer	0.000579	0.00186	CcSEcCtD
Pentosan Polysulfate—Pruritus—Temozolomide—skin cancer	0.000561	0.00181	CcSEcCtD
Pentosan Polysulfate—Nausea—Bleomycin—skin cancer	0.000559	0.0018	CcSEcCtD
Pentosan Polysulfate—Vomiting—Dactinomycin—skin cancer	0.000558	0.0018	CcSEcCtD
Pentosan Polysulfate—Rash—Dactinomycin—skin cancer	0.000553	0.00178	CcSEcCtD
Pentosan Polysulfate—Myalgia—Docetaxel—skin cancer	0.00055	0.00177	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Docetaxel—skin cancer	0.00055	0.00177	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Temozolomide—skin cancer	0.000543	0.00175	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Fluorouracil—skin cancer	0.000538	0.00173	CcSEcCtD
Pentosan Polysulfate—Oedema—Docetaxel—skin cancer	0.000528	0.0017	CcSEcCtD
Pentosan Polysulfate—Dizziness—Temozolomide—skin cancer	0.000525	0.00169	CcSEcCtD
Pentosan Polysulfate—Infection—Docetaxel—skin cancer	0.000524	0.00169	CcSEcCtD
Pentosan Polysulfate—Nausea—Dactinomycin—skin cancer	0.000521	0.00168	CcSEcCtD
Pentosan Polysulfate—Pruritus—Fluorouracil—skin cancer	0.000517	0.00167	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Docetaxel—skin cancer	0.000517	0.00166	CcSEcCtD
Pentosan Polysulfate—Vomiting—Temozolomide—skin cancer	0.000504	0.00162	CcSEcCtD
Pentosan Polysulfate—Anorexia—Docetaxel—skin cancer	0.000503	0.00162	CcSEcCtD
Pentosan Polysulfate—Rash—Temozolomide—skin cancer	0.0005	0.00161	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Fluorouracil—skin cancer	0.0005	0.00161	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Temozolomide—skin cancer	0.0005	0.00161	CcSEcCtD
Pentosan Polysulfate—Headache—Temozolomide—skin cancer	0.000497	0.0016	CcSEcCtD
Pentosan Polysulfate—Dizziness—Fluorouracil—skin cancer	0.000483	0.00156	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000481	0.00155	CcSEcCtD
Pentosan Polysulfate—Insomnia—Docetaxel—skin cancer	0.000477	0.00154	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Docetaxel—skin cancer	0.000474	0.00153	CcSEcCtD
Pentosan Polysulfate—Nausea—Temozolomide—skin cancer	0.000471	0.00152	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Docetaxel—skin cancer	0.00047	0.00152	CcSEcCtD
Pentosan Polysulfate—Vomiting—Fluorouracil—skin cancer	0.000465	0.0015	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Docetaxel—skin cancer	0.000464	0.0015	CcSEcCtD
Pentosan Polysulfate—Rash—Fluorouracil—skin cancer	0.000461	0.00148	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Fluorouracil—skin cancer	0.00046	0.00148	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Docetaxel—skin cancer	0.000459	0.00148	CcSEcCtD
Pentosan Polysulfate—Headache—Fluorouracil—skin cancer	0.000458	0.00148	CcSEcCtD
Pentosan Polysulfate—Constipation—Docetaxel—skin cancer	0.000451	0.00145	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Docetaxel—skin cancer	0.000435	0.0014	CcSEcCtD
Pentosan Polysulfate—Nausea—Fluorouracil—skin cancer	0.000434	0.0014	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Docetaxel—skin cancer	0.000431	0.00139	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Docetaxel—skin cancer	0.000417	0.00134	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Docetaxel—skin cancer	0.000389	0.00125	CcSEcCtD
Pentosan Polysulfate—Pruritus—Docetaxel—skin cancer	0.000373	0.0012	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by EGFR—NRAS—skin cancer	0.000371	0.00102	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—FOXO4—skin cancer	0.000371	0.00102	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—BRAF—skin cancer	0.00037	0.00102	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling of activated FGFR—KRAS—skin cancer	0.00037	0.00102	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Regulation of Actin Cytoskeleton—KRAS—skin cancer	0.00037	0.00102	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—NRAS—skin cancer	0.000368	0.00101	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—NRAS—skin cancer	0.000368	0.00101	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by Insulin receptor—IL6—skin cancer	0.000368	0.00101	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—NRAS—skin cancer	0.000366	0.00101	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—NRAS—skin cancer	0.000366	0.00101	CbGpPWpGaD
Pentosan Polysulfate—FGF4—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	0.000366	0.00101	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—NRAS—skin cancer	0.000365	0.001	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB4—KRAS—skin cancer	0.000364	0.001	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 signaling—NRAS—skin cancer	0.000363	0.001	CbGpPWpGaD
Pentosan Polysulfate—Diarrhoea—Docetaxel—skin cancer	0.000361	0.00116	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling Pathways—PTCH2—skin cancer	0.000358	0.000986	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—NRAS—skin cancer	0.000358	0.000985	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—KRAS—skin cancer	0.000352	0.000971	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by Insulin receptor—HRAS—skin cancer	0.00035	0.000965	CbGpPWpGaD
Pentosan Polysulfate—Dizziness—Docetaxel—skin cancer	0.000349	0.00112	CcSEcCtD
Pentosan Polysulfate—FGF1—Downstream signal transduction—KRAS—skin cancer	0.000348	0.000957	CbGpPWpGaD
Pentosan Polysulfate—FGF1—B Cell Activation—NRAS—skin cancer	0.000346	0.000954	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR—KRAS—skin cancer	0.000346	0.000953	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—KRAS—skin cancer	0.000346	0.000952	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—KRAS—skin cancer	0.000344	0.000948	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 signaling—KRAS—skin cancer	0.000342	0.000943	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—NRAS—skin cancer	0.000341	0.00094	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—NRAS—skin cancer	0.000341	0.00094	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—NRAS—skin cancer	0.000341	0.00094	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—NRAS—skin cancer	0.000338	0.000932	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling events of B Cell Receptor (BCR)—KRAS—skin cancer	0.000338	0.00093	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Regulation of Actin Cytoskeleton—KRAS—skin cancer	0.000337	0.000929	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling of activated FGFR—KRAS—skin cancer	0.000337	0.000929	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Docetaxel—skin cancer	0.000335	0.00108	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—NRAS—skin cancer	0.000335	0.000924	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by Insulin receptor—IL6—skin cancer	0.000335	0.000923	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—NRAS—skin cancer	0.000334	0.00092	CbGpPWpGaD
Pentosan Polysulfate—Rash—Docetaxel—skin cancer	0.000333	0.00107	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Docetaxel—skin cancer	0.000332	0.00107	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—KRAS—skin cancer	0.000332	0.000914	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—NRAS—skin cancer	0.000332	0.000913	CbGpPWpGaD
Pentosan Polysulfate—Headache—Docetaxel—skin cancer	0.00033	0.00106	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by SCF-KIT—HRAS—skin cancer	0.000328	0.000905	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—KRAS—skin cancer	0.000322	0.000888	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—KRAS—skin cancer	0.000322	0.000888	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—KRAS—skin cancer	0.000322	0.000888	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR—KRAS—skin cancer	0.000319	0.00088	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SHH—skin cancer	0.000318	0.000877	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—KRAS—skin cancer	0.000317	0.000873	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—KRAS—skin cancer	0.000316	0.000872	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—RASA1—skin cancer	0.000316	0.000872	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—NRAS—skin cancer	0.000316	0.00087	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—KRAS—skin cancer	0.000315	0.000869	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—KRAS—skin cancer	0.000315	0.000868	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by SCF-KIT—IL6—skin cancer	0.000314	0.000866	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling of activated FGFR—HRAS—skin cancer	0.000314	0.000866	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—KRAS—skin cancer	0.000314	0.000864	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Docetaxel—skin cancer	0.000313	0.00101	CcSEcCtD
Pentosan Polysulfate—FGF2—DAP12 signaling—KRAS—skin cancer	0.000312	0.00086	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB4—HRAS—skin cancer	0.000309	0.000852	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—KRAS—skin cancer	0.000308	0.000848	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	0.000303	0.000835	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—NRAS—skin cancer	0.000302	0.000833	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PTCH1—skin cancer	0.000302	0.000832	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SMO—skin cancer	0.000302	0.000832	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling of activated FGFR—IL6—skin cancer	0.000301	0.000829	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—HRAS—skin cancer	0.0003	0.000825	CbGpPWpGaD
Pentosan Polysulfate—FGF1—B Cell Activation—KRAS—skin cancer	0.000298	0.000821	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—GLI2—skin cancer	0.000297	0.000819	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB4—IL6—skin cancer	0.000296	0.000816	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signal transduction—HRAS—skin cancer	0.000295	0.000814	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR—HRAS—skin cancer	0.000294	0.00081	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—HRAS—skin cancer	0.000294	0.00081	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PTGER4—skin cancer	0.000294	0.000809	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—KRAS—skin cancer	0.000294	0.000809	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—KRAS—skin cancer	0.000294	0.000809	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—KRAS—skin cancer	0.000294	0.000809	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—HRAS—skin cancer	0.000292	0.000806	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—KRAS—skin cancer	0.000291	0.000802	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 signaling—HRAS—skin cancer	0.000291	0.000802	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—SHH—skin cancer	0.000289	0.000795	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—ENO2—skin cancer	0.000289	0.000795	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—KRAS—skin cancer	0.000289	0.000795	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—KRAS—skin cancer	0.000287	0.000791	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling events of B Cell Receptor (BCR)—HRAS—skin cancer	0.000287	0.00079	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—IL6—skin cancer	0.000287	0.00079	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling of activated FGFR—HRAS—skin cancer	0.000287	0.00079	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—KRAS—skin cancer	0.000285	0.000786	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MC1R—skin cancer	0.000284	0.000781	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signal transduction—IL6—skin cancer	0.000283	0.000779	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—HRAS—skin cancer	0.000282	0.000777	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR—IL6—skin cancer	0.000281	0.000775	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—IL6—skin cancer	0.000281	0.000775	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—IL6—skin cancer	0.00028	0.000771	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—GLI1—skin cancer	0.00028	0.00077	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 signaling—IL6—skin cancer	0.000279	0.000767	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	0.000276	0.000762	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling of activated FGFR—IL6—skin cancer	0.000274	0.000756	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—HRAS—skin cancer	0.000274	0.000754	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—HRAS—skin cancer	0.000274	0.000754	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	0.000274	0.000754	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—KRAS—skin cancer	0.000272	0.000749	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR—HRAS—skin cancer	0.000271	0.000748	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—GLI2—skin cancer	0.000271	0.000747	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—CDK4—skin cancer	0.00027	0.000744	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—IL6—skin cancer	0.00027	0.000744	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	0.000269	0.000742	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—HRAS—skin cancer	0.000269	0.000742	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—HRAS—skin cancer	0.000269	0.000741	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—HRAS—skin cancer	0.000268	0.000738	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—HRAS—skin cancer	0.000268	0.000738	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—HRAS—skin cancer	0.000267	0.000735	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 signaling—HRAS—skin cancer	0.000265	0.000731	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SUFU—skin cancer	0.000265	0.00073	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—ERCC2—skin cancer	0.000264	0.000728	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—SHH—skin cancer	0.000263	0.000725	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—ENO2—skin cancer	0.000263	0.000725	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—IL6—skin cancer	0.000262	0.000722	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	0.000262	0.000722	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—IL6—skin cancer	0.000262	0.000722	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—HRAS—skin cancer	0.000262	0.000721	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—KRAS—skin cancer	0.00026	0.000717	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR—IL6—skin cancer	0.00026	0.000716	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—FOXO4—skin cancer	0.00026	0.000715	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MC1R—skin cancer	0.000259	0.000713	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—IL6—skin cancer	0.000258	0.00071	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—IL6—skin cancer	0.000257	0.000709	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—IL6—skin cancer	0.000257	0.000707	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—IL6—skin cancer	0.000256	0.000706	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—IL6—skin cancer	0.000255	0.000703	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—NRAS—skin cancer	0.000255	0.000702	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—GLI1—skin cancer	0.000255	0.000702	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—FOXO4—skin cancer	0.000255	0.000702	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 signaling—IL6—skin cancer	0.000254	0.0007	CbGpPWpGaD
Pentosan Polysulfate—FGF1—B Cell Activation—HRAS—skin cancer	0.000253	0.000698	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—HRAS—skin cancer	0.00025	0.000688	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—HRAS—skin cancer	0.00025	0.000688	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	0.00025	0.000688	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—TERT—skin cancer	0.000248	0.000682	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—HRAS—skin cancer	0.000247	0.000682	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	0.000246	0.000677	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—HRAS—skin cancer	0.000245	0.000676	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—HRAS—skin cancer	0.000244	0.000673	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	0.000243	0.000668	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SUFU—skin cancer	0.000242	0.000666	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—IL6—skin cancer	0.000239	0.000658	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	0.000239	0.000658	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—IL6—skin cancer	0.000239	0.000658	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—IL6—skin cancer	0.000237	0.000653	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—FOXO4—skin cancer	0.000235	0.000648	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—IL6—skin cancer	0.000235	0.000647	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—IL6—skin cancer	0.000234	0.000644	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—NRAS—skin cancer	0.000233	0.000641	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—FOXO4—skin cancer	0.000232	0.00064	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	0.000232	0.000639	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—HRAS—skin cancer	0.000231	0.000637	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—NRAS—skin cancer	0.000229	0.000631	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	0.000221	0.000609	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—NRAS—skin cancer	0.00022	0.000606	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—KRAS—skin cancer	0.000219	0.000605	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—FOXO4—skin cancer	0.000215	0.000591	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	0.000212	0.000583	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SHH—skin cancer	0.000202	0.000557	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—RASA1—skin cancer	0.000201	0.000553	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—KRAS—skin cancer	0.0002	0.000551	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—KRAS—skin cancer	0.000197	0.000543	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—BRAF—skin cancer	0.000196	0.00054	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PTCH1—skin cancer	0.000192	0.000528	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SMO—skin cancer	0.000192	0.000528	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—KRAS—skin cancer	0.000189	0.000522	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—HRAS—skin cancer	0.000187	0.000514	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PTGER4—skin cancer	0.000187	0.000514	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SHH—skin cancer	0.000184	0.000508	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—RASA1—skin cancer	0.000183	0.000505	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—IL6—skin cancer	0.000179	0.000492	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PTCH1—skin cancer	0.000175	0.000481	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SMO—skin cancer	0.000175	0.000481	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TERT—skin cancer	0.000173	0.000478	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—HRAS—skin cancer	0.00017	0.000469	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PTGER4—skin cancer	0.00017	0.000469	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—ERCC2—skin cancer	0.000168	0.000462	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—HRAS—skin cancer	0.000168	0.000462	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FOXO4—skin cancer	0.000165	0.000454	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—IL6—skin cancer	0.000163	0.000449	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—HRAS—skin cancer	0.000161	0.000443	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—IL6—skin cancer	0.00016	0.000442	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PTGS2—skin cancer	0.000158	0.000436	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—TERT—skin cancer	0.000157	0.000433	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—ERCC2—skin cancer	0.000153	0.000421	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FOXO4—skin cancer	0.00015	0.000414	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—NRAS—skin cancer	0.00015	0.000414	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—NRAS—skin cancer	0.000145	0.000401	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—TERT—skin cancer	0.000143	0.000395	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—NRAS—skin cancer	0.00014	0.000385	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—BRAF—skin cancer	0.000137	0.000378	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—NRAS—skin cancer	0.000133	0.000368	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—NRAS—skin cancer	0.000133	0.000365	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—KRAS—skin cancer	0.000129	0.000356	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—NRAS—skin cancer	0.000127	0.000351	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—KRAS—skin cancer	0.000125	0.000345	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—BRAF—skin cancer	0.000124	0.000343	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—NRAS—skin cancer	0.000123	0.000339	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—KRAS—skin cancer	0.00012	0.000331	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—KRAS—skin cancer	0.000115	0.000316	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—KRAS—skin cancer	0.000114	0.000314	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—BRAF—skin cancer	0.000113	0.000313	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TERT—skin cancer	0.00011	0.000303	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—HRAS—skin cancer	0.00011	0.000303	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—KRAS—skin cancer	0.00011	0.000302	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—HRAS—skin cancer	0.000106	0.000293	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—KRAS—skin cancer	0.000106	0.000292	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—IL6—skin cancer	0.000105	0.00029	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—HRAS—skin cancer	0.000102	0.000281	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—IL6—skin cancer	0.000102	0.000281	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTGS2—skin cancer	0.000101	0.000277	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TERT—skin cancer	0.0001	0.000276	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—HRAS—skin cancer	9.76e-05	0.000269	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—HRAS—skin cancer	9.7e-05	0.000267	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL6—skin cancer	9.34e-05	0.000257	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—HRAS—skin cancer	9.32e-05	0.000257	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—IL6—skin cancer	9.29e-05	0.000256	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTGS2—skin cancer	9.17e-05	0.000253	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—HRAS—skin cancer	9.01e-05	0.000248	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—BRAF—skin cancer	8.71e-05	0.00024	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NRAS—skin cancer	8.63e-05	0.000238	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—IL6—skin cancer	8.63e-05	0.000238	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—NRAS—skin cancer	8.47e-05	0.000233	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—BRAF—skin cancer	7.95e-05	0.000219	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NRAS—skin cancer	7.82e-05	0.000215	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—NRAS—skin cancer	7.72e-05	0.000213	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KRAS—skin cancer	7.43e-05	0.000205	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KRAS—skin cancer	7.29e-05	0.000201	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NRAS—skin cancer	7.13e-05	0.000196	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—KRAS—skin cancer	6.73e-05	0.000185	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KRAS—skin cancer	6.65e-05	0.000183	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TP53—skin cancer	6.6e-05	0.000182	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HRAS—skin cancer	6.31e-05	0.000174	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—HRAS—skin cancer	6.2e-05	0.000171	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—KRAS—skin cancer	6.14e-05	0.000169	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL6—skin cancer	6.04e-05	0.000166	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL6—skin cancer	5.93e-05	0.000163	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HRAS—skin cancer	5.72e-05	0.000158	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—HRAS—skin cancer	5.65e-05	0.000156	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NRAS—skin cancer	5.48e-05	0.000151	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—IL6—skin cancer	5.48e-05	0.000151	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL6—skin cancer	5.41e-05	0.000149	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HRAS—skin cancer	5.22e-05	0.000144	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NRAS—skin cancer	4.99e-05	0.000138	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—IL6—skin cancer	4.99e-05	0.000138	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KRAS—skin cancer	4.71e-05	0.00013	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KRAS—skin cancer	4.3e-05	0.000118	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TP53—skin cancer	4.19e-05	0.000115	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HRAS—skin cancer	4.01e-05	0.00011	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL6—skin cancer	3.83e-05	0.000106	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TP53—skin cancer	3.82e-05	0.000105	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HRAS—skin cancer	3.65e-05	0.000101	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL6—skin cancer	3.5e-05	9.63e-05	CbGpPWpGaD
